Moneycontrol
HomeNewsBusinessReal EstateSenior living homes in India: Southern cities dominate with almost 70% share of projects
Trending Topics

Senior living homes in India: Southern cities dominate with almost 70% share of projects

Of the total 55 projects for senior living homes in India, 60 percent are in Tier 2 and 40 percent in Tier 1 cities

August 17, 2020 / 15:33 IST
Story continues below Advertisement

COVID-19 may push up demand for senior living homes in India. While the South Indian market dominates in this category, there are only 55 projects across the country of which 60 percent are located in tier 2 cities and the remaining 40 percent in Tier 1 cities, Anarock has said in a report.

Senior living projects have sprung up mainly in the outskirts of the major cities and in tier II and III cities across the country. Bhiwadi in NCR, Neral in Mumbai, Talegaon in Pune and Devanahalli in Bengaluru are some of the prominent locations around Tier 1 cities, while tier 2 and 3 cities have more supply - a 60 percent share in approximately 33 projects. Tier 1 cities have just 22 projects dedicated to seniors, it said.

Story continues below Advertisement

Prominent tier 2 cities include Coimbatore, Puducherry, Kodaikanal, Vadodara, Bhopal, Jaipur, Mysuru, Dehradun, Kasauli and Kanchipuram, among others. Key Tier 1 cities are Bengaluru, Chennai, Pune, Noida.

Region-wise, the southern cities have a nearly 69 percent share of these projects, coinciding with the demographic assumption that elderly population growth in the southern states will grow at a faster pace than the rest of India, according to a report by SBI.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show